Our study investigates the hypothesis that DSS ameliorates AD pathology via AMPK/Sp1/ACSL4 axis-mediated regulation of neuronal lipid metabolism and ferroptosis suppression, using the APP/PS1 transgenic mouse model. Here, PRKAA1 is linked to Alzheimer disease.